Browse > Article
http://dx.doi.org/10.4333/KPS.2010.40.4.245

Pharmaceutical Potential of Gelatin as a pH-responsive Porogen for Manufacturing Porous Poly(d,l-lactic-co-glycolic acid) Microspheres  

Kim, Hyun-Uk (College of Pharmacy, Pusan National University)
Park, Hong-Il (College of Pharmacy, Pusan National University)
Lee, Ju-Ho (College of Pharmacy, Pusan National University)
Lee, Eun-Seong (Division of Biotechnology, The Catholic University of Korea)
Oh, Kyung-Taek (College of Pharmacy, Chung-Ang University)
Yoon, Jeong-Hyun (College of Pharmacy, Pusan National University)
Park, Eun-Seok (College of Pharmacy, Sungkyunkwan University)
Lee, Kang-Choon (College of Pharmacy, Sungkyunkwan University)
Youn, Yu-Seok (College of Pharmacy, Pusan National University)
Publication Information
Journal of Pharmaceutical Investigation / v.40, no.4, 2010 , pp. 245-250 More about this Journal
Abstract
Porous poly(lactic-co-glycolic acid) microspheres (PLGA MS) have been utilized as an inhalation delivery system and a matrix scaffold system for tissue engineering. Here, gelatin (type A) is introduced as an extractable pH-responsive porogen, which is capable of controlling the porosity and pore size of PLGA microspheres. Porous PLGA microspheres were prepared by a water-in-oil-in-water ($w_1/o/w_2$) double emulsification/solvent evaporation method. The surface morphology of these microspheres was examined by varying pH (2.0~11.0) of water phases, using scanning electron microscopy (SEM). Also, their porosity and pore size were monitored by altering acidification time (1~5 h) using a phosphoric acid solution. Results showed that the pore-forming capability of gelatin was optimized at pH 5.0, and that the surface pore-formation was not significantly observed at pHs of < 4.0 or > 8.0. This was attributable to the balance between gel-formation by electrostatic repulsion and dissolution of gelatin. The appropriate time-selection between PLGA hardening and gelatin-washing out was considered as a second significant factor to control the porosity. Delaying the acidification time to ~5 h after emulsification was clearly effective to make pores in the microspheres. This finding suggests that the porosity and pore size of porous microspheres using gelatin can be significantly controlled depending on water phase pH and gelatin-removal time. The results obtained in this study would provide valuable pharmaceutical information to prepare porous PLGA MS, which is required to control the porosity.
Keywords
porous microspheres; gelatin; PLGA; porogen; pH-responsive;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ungaro, F., De Rosa, G., Miro, A., Quaglia, F., Immacolata La Rotonda, M., 2006. Cyclodextrins in the production of large porous particles: Development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 28, 423-432.   DOI
2 Yang, Y., Bajaj, N., Xu, P., Ohn, K., Tsifansky, M.D., Yeo, Y., 2009. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 30, 1947-1953.   DOI
3 Youn, Y.S., Lee, K.C., Bae, Y.H., Na, K., Lee, E.S., 2009. Advanced pulmonary delivery of peptides or proteins using polymeric particles in Delivery technologies for biopharmaceuticals: Peptides, proteins, nucleic acids, and vaccines. WILEY. 228-244.
4 Young, S., Wong, M., Tabata, Y., Mikos, A.G., 2005. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release. 109, 256-274.   DOI
5 Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M.L., Mintzes , J., Deaver , D., Lotan, N., Langer, R., 1997. Large porous particles for pulmonary drug delivery. Science. 276, 1868-1871.   DOI
6 Gombotz, W.R., Pettit, D.K., 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem. 6, 332-351.   DOI
7 Kang, S.-W., Bae, Y.H., 2009. Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere. Biomaterials. 30, 4227-4232   DOI
8 Kwon, M.J., Bae, J.H., Kim, J.J., Na, K., Lee, E.S., 2007. Long acting porous microparticles for pulmonary drug delivery. Int. J. Pharm. 333, 5-9.
9 Kim, H.K., Chung, H.J., Park, T.G., 2006. Biodegradable polymeric microspheres with “open/closed” pores for sustained release of human growth hormone, J. Control. Release. 112, 167-174.   DOI
10 Kim, T.K., Yoon, J.J., Lee, D.S., Park, T.G., 2006. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials. 27, 152-159.   DOI
11 Lee, E.S., Kwon, M.J., Na, K., Bae, J.H., 2007. Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex. Colloids Surfs. B. 55, 125-130.   DOI
12 Park, H.I., Kim, H.U., Lee, E.S., Lee, K.C., Youn, Y.S., 2009. Preparation of Highly Porous Poly(d,l-lactic-co-glycolic acid) (PLGA) Microspheres. J. Kor. Pharm. Sci. 39, 167-171.   DOI
13 Sun, L., Zhou, S., Wang, W., Li, X., Wang, J., Weng, J., 2009. Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surfs. A. 345, 173-181.   DOI
14 Edwards, D.A., Ben-Jebria, A., Langer, R., 1998. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 85, 379-385.
15 Chung, H.J., Kim, H.K., Yoon, J.J., Park, T.G., 2006. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm. Res. 23, 1835-1841.   DOI
16 Cohen, S., Yoshioka, Y., Lucarelli, M., Hwang, L.H., Langer, R., 1991. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8, 713-720.   DOI